Related references
Note: Only part of the references are listed.Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus
Mingming Li et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2022)
Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis
Claudia Mellenthin et al.
CANCERS (2022)
Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample
Pauline C. S. van Paridon et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort
Barnabas Gellen et al.
DIABETOLOGIA (2020)
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development
Anni M. Y. Zhang et al.
CELL METABOLISM (2019)
Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes
Ayush Sharma et al.
GASTROENTEROLOGY (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
Seetharaman Balasenthil et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
Seetharaman Balasenthil et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
New-onset type 2 diabetes mellitus - A high-risk the screening of pancreatic cancer? group suitable for the screening of pancreatic cancer?
Dora Illes et al.
PANCREATOLOGY (2016)
Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2
Barbara Ruszkowska-Ciastek et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Pikli Batabyal et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Migration Signature and Plasma Biomarker Panel for Pancreatic Adenocarcinoma
Seetharaman Balasenthil et al.
CANCER PREVENTION RESEARCH (2011)
Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L
Robert R. McWilliams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Pancreatic cancer-associated diabetes mellitus: Prevalence and temporal association with diagnosis of cancer
Suresh T. Chari et al.
GASTROENTEROLOGY (2008)
Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?
J Damiano et al.
DIABETES & METABOLISM (2004)
Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: Influence of type of diabetes, obesity index, and age
A Vambergue et al.
THROMBOSIS RESEARCH (2001)
Share Paper
